Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)

China flag China · Delayed Price · Currency is CNY
3.640
+0.060 (1.68%)
Jul 3, 2026, 3:04 PM CST
Market Cap4.33B -13.5%
Revenue (ttm)1.68B -18.1%
Net Income62.86M -72.2%
EPS0.05 -74.9%
Shares Out 1.19B
PE Ratio73.55
Forward PEn/a
Dividend0.07 (1.92%)
Ex-Dividend DateMay 28, 2026
Volume18,211,045
Open3.430
Previous Close3.580
Day's Range3.430 - 3.650
52-Week Range3.240 - 5.480
Beta0.27
Analystsn/a
Price Targetn/a
Earnings DateAug 27, 2026

About SHE:300194

Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China. It offers APIs; intermediates; and FFPs, such as anti-tumor, generic drugs, antibiotics and oral, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. The company was founded in 2004 and is headquartered in Chongqing, the Peopl... [Read more]

Sector Healthcare
Founded 2004
Employees 2,988
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300194
Full Company Profile

Financial Performance

In 2025, SHE:300194's revenue was 1.74 billion, a decrease of -27.31% compared to the previous year's 2.39 billion. Earnings were 77.00 million, a decrease of -72.49%.

Financial Statements